Amarin announces senior management changes

Connecticut firm appoints ceo, president and principal accountant

Amarin Corporation, a US clinical-stage biopharmaceutical company with a focus on cardiovascular disease, has appointed Joseph Zakrzewski as chief executive. He will continue to serve as chairman of the board.

Zakrzewski has more than 20 years of experience, including holding the position of chief operating officer of Reliant Pharmaceuticals when Omacor/Lovaza was developed and acquired in 2007 by GlaxoSmithKline. He was most recently chief executive of Xcellerex, a Massachusetts-based biotechnology company. Although he currently serves on the boards of directors and in other advisory roles for various companies, Amarin is his primary business commitment.

Additionally, John Thero has been promoted to Amarin’s president. Since November 2009, he has been the company’s chief financial officer.

Prior to joining Amarin, Thero was chief financial officer at ViaCell, where he helped guide the sale of the company, and Abiomed, during its transition from a development-stage company into a commercial entity.

Colin Stewart, who was Amarin’s president and ceo, resigned last month to address personal matters.

In connection with these changes, Frederick Ahlholm, vice president finance, has become the company’s principal accounting officer.

You may also like

Pharmaceutical

Optimising process steps and performance with agitated Nutsche filter-dryers

Agitated Nutsche filter dryers (ANFD) streamline solid-liquid separation by performing filtration, dewatering, and drying in a single sealed vessel; an enormous boon in fine chemicals and pharmaceutical production
Design & Build

Cleanroom Technology launches global cleanroom awards

Introducing the Cleanroom Technology Awards, the global benchmark for cleanroom excellence
Sustainability

ACG Packaging Materials becomes first pharma packaging firm to join WEF Lighthouse Network

The company has joined the World Economic Forum’s Global Lighthouse Network after its Shirwal facility was named a Lighthouse site, making it the world’s first pharmaceutical packaging company to receive the recognition for smart, sustainable manufacturing
Pharmaceutical

testo Saveris 1 update automates environmental monitoring workflows for pharma compliance

New features include automated workflows for efficient environmental monitoring, approvals for secure and compliant changes, and more flexible control of webhooks, as well as further improvements in performance, transparency and usability
Regulatory

Hims & Hers backs down on oral GLP-1 copycat after FDA pressure

Facing threats of legal action from Wegovy manufacturer Novo Nordisk and an FDA probe, the health and wellness company has decided to abandon its plans to offer a GLP-1 copycat
Pharmaceutical

PharmNovo enhances its board ahead of Phase II development

The new board members bring complementary experience in drug development, clinical execution and partnering, supporting the company’s continued progress and dialogue with potential partners
Research & Development

AdvanCell partners with 48Hour Discovery on peptide-based lead-212 radiotherapeutic

The pair will develop a novel peptide-based Lead-212 radiotherapeutic targeting a gastrointestinal cancer with significant unmet need, strengthening AdcanCell's pipeline of differentiated targeted alpha therapies
Subscribe now